Primary Research · 2019
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia (REDUCE-IT)
Bhatt DL, Steg PG, Miller M, et al. · New England Journal of Medicine, 2019
Key finding
Double-blind RCT (n=8,179) found high-dose EPA (4g/day) reduced ischemic events by 25% vs placebo in patients with elevated triglycerides on statins — the most convincing cardiovascular benefit data for omega-3s.
About the supplement
Omega-3 Fatty Acids
Dose · mechanism · evidence grade · safety →
Read the paper
Open on PubMedhttps://pubmed.ncbi.nlm.nih.gov/30415628/
Cited in 3 guides
Guide
Longevity Supplement Stack for Beginners 2026
Learn which longevity supplements are actually backed by human evidence. We tier NAD+, omega-3s, and more by clinical strength — no hype, no wasted money.
Roundup
Best Omega-3 Supplements 2026, Ranked by Clinical Evidence
Learn to decode EPA+DHA labels, absorption forms, and oxidation scores. We ranked 8 omega-3 supplements using clinical evidence — no guesswork.
Guide
How to Build a Supplement Stack (2026) — Evidence-Based
Skip the influencer hauls. Learn a step-by-step, evidence-based method to build a supplement stack that fits your goals — without wasting money.
About this page
Formulate maintains a registry of clinical studies cited across its guides and evidence grades. This page links the study metadata to the content that cites it — one canonical entry per landmark study.
The full citation chain is public so readers can verify claims without hunting through individual guide pages. Browse all cited studies →
Note: Study summaries on this page are editorial interpretations of the research. Always consult the primary source before drawing clinical conclusions.